83 results
Page 4 of 5
8-K
EX-99.1
irb751c ia6jsv1
6 May 20
Axcella Announces Positive Top-Line Data from AXA1125-003 Clinical Study Showing Multifactorial Activity in Adult Subjects with NAFLD
8:09am
8-K
EX-99.2
s01zjs49wyi
6 May 20
Axcella Announces Positive Top-Line Data from AXA1125-003 Clinical Study Showing Multifactorial Activity in Adult Subjects with NAFLD
8:09am
DRS
509 e2yuqv11
3 Apr 20
Draft registration statement
12:00am
10-K
mtn3fqaj wg5
23 Mar 20
Annual report
4:12pm
8-K
EX-99.1
psn 6y5xqvklz16xyf
23 Mar 20
Axcella Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:03pm
8-K
EX-99.1
f48x5ic7 zuwjy
25 Nov 19
Axcella Strengthens Executive Team with Key Addition and Promotion
8:11am
8-K
xwpl5mfc2gb87 kgx9
12 Nov 19
Results of Operations and Financial Condition
4:04pm
8-K
y9luvqx 4axpa3a
12 Aug 19
Results of Operations and Financial Condition
4:50pm
10-Q
c6dmix5
20 Jun 19
Quarterly report
5:03pm
8-K
328njnopkhge
20 Jun 19
Results of Operations and Financial Condition
4:44pm
424B4
podmrdv pykl2uhi3
9 May 19
Prospectus supplement with pricing info
4:29pm
S-1/A
EX-10.10
mu1ssl6vgylv8k9
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
5pw9ktav5yeaa4h1 tqw
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-1.1
45x7mu u6ir2zb
30 Apr 19
IPO registration (amended)
6:06am
S-1
t5hkn7ok7s 86
12 Apr 19
IPO registration
7:02am
S-1
EX-3.6
7m5d87sm 3dsyc
12 Apr 19
IPO registration
7:02am
DRS/A
leezp0y5qwcrscw
15 Mar 19
Draft registration statement (amended)
12:00am